SS
LYEL icon

Simplicity Solutions’s Lyell Immunopharma LYEL Stock Holding History

Simplicity Solutions’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$93.3K Buy
+2,405
New +$86.6K ﹤0.01% 1017

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplicity Solutions's LYEL Position: Q4 2023 in Review

Simplicity Solutions opened a new position in Lyell Immunopharma (LYEL) in Q4 2023: 2,405 shares worth $93.3K. The stake represents ﹤0.01% of the portfolio and ranks #1017 among its holdings.

118 funds tracked by Wall St. Rank hold LYEL as of Q4 2023.

  • Simplicity Solutions held 2,405 shares of Lyell Immunopharma worth $93.3K as of Q4 2023.
  • Lyell Immunopharma was a new Simplicity Solutions position in Q4 2023.
  • Lyell Immunopharma made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #1017 holding.
  • 118 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.